| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder, Neurogenic | 48 | 2024 | 173 | 7.680 |
Why?
|
| Urodynamics | 70 | 2024 | 346 | 7.080 |
Why?
|
| Urinary Bladder | 63 | 2023 | 1152 | 4.790 |
Why?
|
| Urinary Incontinence | 36 | 2021 | 489 | 3.490 |
Why?
|
| Intermittent Urethral Catheterization | 4 | 2023 | 14 | 3.080 |
Why?
|
| Urination Disorders | 22 | 2018 | 238 | 2.730 |
Why?
|
| Urinary Tract | 21 | 2023 | 313 | 2.520 |
Why?
|
| Meningomyelocele | 22 | 2012 | 171 | 2.320 |
Why?
|
| Urethra | 32 | 2020 | 405 | 2.170 |
Why?
|
| Vesico-Ureteral Reflux | 39 | 2022 | 437 | 1.950 |
Why?
|
| Urinary Bladder Diseases | 17 | 2016 | 167 | 1.550 |
Why?
|
| Urologic Diseases | 7 | 2016 | 247 | 1.490 |
Why?
|
| Neural Tube Defects | 12 | 2017 | 255 | 1.480 |
Why?
|
| Botulinum Toxins, Type A | 4 | 2024 | 237 | 1.440 |
Why?
|
| Spinal Dysraphism | 7 | 2024 | 178 | 1.400 |
Why?
|
| Urogenital Abnormalities | 9 | 2022 | 261 | 1.220 |
Why?
|
| Urology | 7 | 2024 | 400 | 1.210 |
Why?
|
| Nocturnal Enuresis | 4 | 2019 | 12 | 1.050 |
Why?
|
| Diagnostic Techniques, Urological | 4 | 2015 | 28 | 1.030 |
Why?
|
| Urinary Bladder, Overactive | 5 | 2021 | 115 | 1.030 |
Why?
|
| Fecal Incontinence | 5 | 2015 | 241 | 1.010 |
Why?
|
| Neuromuscular Agents | 3 | 2024 | 147 | 0.930 |
Why?
|
| Child | 175 | 2024 | 80162 | 0.910 |
Why?
|
| Ureter | 15 | 2016 | 367 | 0.880 |
Why?
|
| Urinary Tract Infections | 15 | 2023 | 803 | 0.860 |
Why?
|
| Urinary Catheterization | 12 | 2023 | 193 | 0.710 |
Why?
|
| Urination | 13 | 2022 | 203 | 0.680 |
Why?
|
| Losartan | 1 | 2021 | 265 | 0.640 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2021 | 431 | 0.600 |
Why?
|
| Defecation | 3 | 2017 | 190 | 0.570 |
Why?
|
| Child, Preschool | 110 | 2024 | 42254 | 0.550 |
Why?
|
| Constipation | 5 | 2015 | 562 | 0.550 |
Why?
|
| Terminology as Topic | 5 | 2015 | 1535 | 0.490 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 602 | 0.480 |
Why?
|
| Spinal Cord | 11 | 2017 | 1818 | 0.470 |
Why?
|
| Urologic Surgical Procedures | 6 | 2024 | 298 | 0.450 |
Why?
|
| Cerebral Palsy | 3 | 2017 | 474 | 0.440 |
Why?
|
| Fibrosis | 1 | 2021 | 2048 | 0.440 |
Why?
|
| Varicocele | 6 | 2015 | 75 | 0.430 |
Why?
|
| Urethral Diseases | 4 | 2018 | 52 | 0.420 |
Why?
|
| Infant | 85 | 2020 | 36205 | 0.420 |
Why?
|
| Neurogenic Bowel | 1 | 2012 | 1 | 0.410 |
Why?
|
| Ureteral Obstruction | 11 | 2011 | 293 | 0.410 |
Why?
|
| Glycopeptides | 1 | 2013 | 220 | 0.400 |
Why?
|
| Digestive System Abnormalities | 1 | 2012 | 49 | 0.400 |
Why?
|
| Syringomyelia | 1 | 2012 | 67 | 0.390 |
Why?
|
| Humans | 231 | 2024 | 761423 | 0.380 |
Why?
|
| Writing | 1 | 2013 | 199 | 0.380 |
Why?
|
| Kidney | 23 | 2022 | 7049 | 0.380 |
Why?
|
| Biofeedback, Psychology | 2 | 2009 | 116 | 0.370 |
Why?
|
| Urography | 11 | 2016 | 316 | 0.370 |
Why?
|
| Antidiuretic Agents | 2 | 2012 | 21 | 0.370 |
Why?
|
| Adolescent | 93 | 2024 | 88313 | 0.360 |
Why?
|
| Intestines | 5 | 2017 | 1909 | 0.360 |
Why?
|
| Consensus | 7 | 2024 | 3122 | 0.360 |
Why?
|
| Deamino Arginine Vasopressin | 2 | 2012 | 87 | 0.360 |
Why?
|
| Mandelic Acids | 4 | 1999 | 46 | 0.350 |
Why?
|
| Urinary Sphincter, Artificial | 2 | 2008 | 23 | 0.340 |
Why?
|
| Pediatrics | 5 | 2024 | 3595 | 0.330 |
Why?
|
| Quality of Life | 5 | 2017 | 13361 | 0.320 |
Why?
|
| Diverticulum | 4 | 2009 | 137 | 0.320 |
Why?
|
| Self Concept | 1 | 2015 | 1043 | 0.320 |
Why?
|
| Male | 161 | 2024 | 360736 | 0.310 |
Why?
|
| Hydronephrosis | 15 | 2011 | 271 | 0.310 |
Why?
|
| Kidney Pelvis | 4 | 2017 | 186 | 0.310 |
Why?
|
| Hypospadias | 8 | 2001 | 97 | 0.310 |
Why?
|
| Intestine, Small | 1 | 2014 | 1205 | 0.300 |
Why?
|
| Infant, Newborn | 52 | 2018 | 26212 | 0.300 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 3460 | 0.290 |
Why?
|
| Cholinergic Antagonists | 4 | 2003 | 168 | 0.290 |
Why?
|
| Tissue Engineering | 3 | 2014 | 1867 | 0.280 |
Why?
|
| Fetus | 3 | 2012 | 1864 | 0.280 |
Why?
|
| Pressure | 6 | 2018 | 1155 | 0.280 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 1385 | 0.280 |
Why?
|
| Patient Compliance | 4 | 2015 | 2690 | 0.280 |
Why?
|
| Urethral Stricture | 3 | 2017 | 50 | 0.270 |
Why?
|
| Fetal Diseases | 2 | 2011 | 913 | 0.260 |
Why?
|
| Toilet Training | 2 | 2019 | 18 | 0.260 |
Why?
|
| Enuresis | 4 | 2006 | 50 | 0.260 |
Why?
|
| Testis | 7 | 2015 | 794 | 0.250 |
Why?
|
| Female | 129 | 2024 | 392581 | 0.250 |
Why?
|
| Bladder Exstrophy | 4 | 2014 | 106 | 0.240 |
Why?
|
| Bulbourethral Glands | 1 | 2004 | 7 | 0.240 |
Why?
|
| Spina Bifida Occulta | 4 | 2000 | 31 | 0.240 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 2319 | 0.240 |
Why?
|
| Sacrum | 5 | 2012 | 276 | 0.240 |
Why?
|
| Postoperative Complications | 20 | 2011 | 15650 | 0.230 |
Why?
|
| Urinary Diversion | 10 | 2003 | 134 | 0.230 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 2632 | 0.230 |
Why?
|
| Genital Diseases, Male | 1 | 2004 | 83 | 0.230 |
Why?
|
| Muscle, Smooth | 5 | 2015 | 926 | 0.230 |
Why?
|
| Adolescent Behavior | 1 | 2012 | 1186 | 0.220 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3030 | 0.210 |
Why?
|
| Guideline Adherence | 1 | 2013 | 2220 | 0.210 |
Why?
|
| Periodicals as Topic | 1 | 2013 | 1463 | 0.200 |
Why?
|
| Meningocele | 3 | 2016 | 47 | 0.200 |
Why?
|
| Ureteral Neoplasms | 1 | 2003 | 106 | 0.200 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2010 | 916 | 0.200 |
Why?
|
| Pedigree | 8 | 2020 | 4589 | 0.200 |
Why?
|
| Polyps | 2 | 2003 | 200 | 0.200 |
Why?
|
| Reproducibility of Results | 9 | 2022 | 20093 | 0.190 |
Why?
|
| Electromyography | 18 | 2020 | 1393 | 0.190 |
Why?
|
| Clinical Protocols | 2 | 2016 | 1440 | 0.180 |
Why?
|
| Ureterostomy | 1 | 2000 | 18 | 0.180 |
Why?
|
| Caregivers | 2 | 2023 | 2237 | 0.180 |
Why?
|
| Cystostomy | 1 | 2000 | 25 | 0.180 |
Why?
|
| Urologic Surgical Procedures, Male | 3 | 2017 | 78 | 0.180 |
Why?
|
| Retrospective Studies | 36 | 2024 | 80582 | 0.180 |
Why?
|
| Urinary Bladder Neck Obstruction | 2 | 2000 | 81 | 0.180 |
Why?
|
| Delphi Technique | 1 | 2024 | 846 | 0.180 |
Why?
|
| Spasm | 1 | 2000 | 130 | 0.170 |
Why?
|
| Ketorolac | 1 | 2000 | 94 | 0.170 |
Why?
|
| Young Adult | 14 | 2022 | 59207 | 0.170 |
Why?
|
| Cysts | 2 | 2004 | 681 | 0.170 |
Why?
|
| Video Recording | 3 | 2015 | 966 | 0.160 |
Why?
|
| Hospitals, Pediatric | 5 | 2024 | 1862 | 0.160 |
Why?
|
| Solanaceous Alkaloids | 1 | 2018 | 3 | 0.150 |
Why?
|
| Fraser Syndrome | 1 | 2018 | 5 | 0.150 |
Why?
|
| Orchiopexy | 1 | 2017 | 20 | 0.150 |
Why?
|
| Follow-Up Studies | 31 | 2019 | 39117 | 0.150 |
Why?
|
| Eye Abnormalities | 1 | 2020 | 242 | 0.150 |
Why?
|
| Fatty Acids, Volatile | 1 | 2018 | 103 | 0.150 |
Why?
|
| Sacrococcygeal Region | 2 | 2016 | 53 | 0.150 |
Why?
|
| Parasympatholytics | 3 | 1994 | 89 | 0.140 |
Why?
|
| Genetic Linkage | 3 | 2012 | 2382 | 0.140 |
Why?
|
| Urethral Obstruction | 1 | 1997 | 55 | 0.140 |
Why?
|
| Rheology | 1 | 2018 | 347 | 0.140 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2018 | 177 | 0.140 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2019 | 269 | 0.140 |
Why?
|
| Urinary Reservoirs, Continent | 4 | 1998 | 29 | 0.140 |
Why?
|
| Cystoscopy | 6 | 2011 | 131 | 0.130 |
Why?
|
| Mutation | 5 | 2020 | 30045 | 0.130 |
Why?
|
| Receptors, Nicotinic | 1 | 2019 | 495 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 2 | 2020 | 1613 | 0.130 |
Why?
|
| Kidney Diseases | 7 | 2012 | 2092 | 0.130 |
Why?
|
| Diurnal Enuresis | 1 | 2015 | 3 | 0.130 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2018 | 170 | 0.130 |
Why?
|
| Societies, Medical | 4 | 2015 | 3905 | 0.130 |
Why?
|
| Urinary Incontinence, Urge | 3 | 2015 | 50 | 0.120 |
Why?
|
| Muscle Weakness | 1 | 2018 | 412 | 0.120 |
Why?
|
| Age Factors | 7 | 2015 | 18400 | 0.120 |
Why?
|
| Disease Management | 2 | 2016 | 2507 | 0.120 |
Why?
|
| Sports | 1 | 2021 | 705 | 0.120 |
Why?
|
| Urinary Tract Physiological Phenomena | 1 | 2014 | 11 | 0.120 |
Why?
|
| Predictive Value of Tests | 5 | 2015 | 15262 | 0.120 |
Why?
|
| Stomach | 4 | 2000 | 696 | 0.120 |
Why?
|
| Tretinoin | 1 | 2017 | 519 | 0.110 |
Why?
|
| Self Care | 4 | 2012 | 796 | 0.110 |
Why?
|
| Spinal Cord Injuries | 4 | 2008 | 925 | 0.110 |
Why?
|
| Sperm Motility | 1 | 2015 | 266 | 0.110 |
Why?
|
| Abnormalities, Multiple | 4 | 2016 | 1424 | 0.110 |
Why?
|
| Students | 1 | 2023 | 1741 | 0.110 |
Why?
|
| Social Participation | 1 | 2015 | 183 | 0.110 |
Why?
|
| Semen Analysis | 1 | 2015 | 236 | 0.110 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 504 | 0.110 |
Why?
|
| T-Box Domain Proteins | 1 | 2015 | 469 | 0.100 |
Why?
|
| Treatment Outcome | 21 | 2016 | 64651 | 0.100 |
Why?
|
| Genes, Dominant | 1 | 2015 | 863 | 0.100 |
Why?
|
| Social Adjustment | 1 | 2015 | 632 | 0.100 |
Why?
|
| Cryptorchidism | 3 | 1999 | 151 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2016 | 8633 | 0.100 |
Why?
|
| Anal Canal | 2 | 2012 | 373 | 0.100 |
Why?
|
| Ureterocele | 3 | 2001 | 28 | 0.100 |
Why?
|
| Urinary Calculi | 3 | 2001 | 90 | 0.100 |
Why?
|
| Time Factors | 16 | 2016 | 39975 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2012 | 410 | 0.090 |
Why?
|
| Parents | 2 | 2022 | 3564 | 0.090 |
Why?
|
| Genes, X-Linked | 1 | 2011 | 128 | 0.090 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 3 | 2000 | 81 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 7389 | 0.090 |
Why?
|
| Enema | 1 | 2011 | 141 | 0.090 |
Why?
|
| Pain | 3 | 2020 | 5071 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2000 | 2273 | 0.090 |
Why?
|
| Rectum | 2 | 2012 | 892 | 0.090 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1991 | 173 | 0.090 |
Why?
|
| Administration, Intravesical | 2 | 2004 | 92 | 0.090 |
Why?
|
| Death, Sudden | 1 | 2012 | 302 | 0.090 |
Why?
|
| Mutation, Missense | 2 | 2018 | 2571 | 0.090 |
Why?
|
| Infant Care | 1 | 2011 | 180 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 8179 | 0.080 |
Why?
|
| Prognosis | 6 | 2019 | 29620 | 0.080 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 26112 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2020 | 2985 | 0.080 |
Why?
|
| Muscarinic Antagonists | 3 | 2015 | 135 | 0.080 |
Why?
|
| Kidney Calices | 1 | 2009 | 26 | 0.080 |
Why?
|
| Testicular Hydrocele | 1 | 2008 | 27 | 0.080 |
Why?
|
| Adult | 42 | 2021 | 221148 | 0.080 |
Why?
|
| Neurologic Examination | 5 | 1997 | 916 | 0.080 |
Why?
|
| International Cooperation | 1 | 2015 | 1422 | 0.080 |
Why?
|
| Rats | 5 | 2021 | 23742 | 0.080 |
Why?
|
| Rupture, Spontaneous | 2 | 2004 | 362 | 0.080 |
Why?
|
| Spermatic Cord Torsion | 2 | 2005 | 72 | 0.080 |
Why?
|
| Disease Progression | 3 | 2017 | 13502 | 0.080 |
Why?
|
| Urachus | 2 | 1998 | 18 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2012 | 15941 | 0.080 |
Why?
|
| Combined Modality Therapy | 5 | 2018 | 8529 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2009 | 386 | 0.070 |
Why?
|
| Urolithiasis | 1 | 2009 | 125 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2018 | 3612 | 0.070 |
Why?
|
| Nomograms | 1 | 2009 | 230 | 0.070 |
Why?
|
| Kidney Neoplasms | 2 | 2003 | 4248 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3798 | 0.070 |
Why?
|
| Physical Examination | 3 | 2012 | 1254 | 0.070 |
Why?
|
| Sperm Count | 1 | 2007 | 229 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 2898 | 0.070 |
Why?
|
| Eosinophilia | 1 | 1991 | 560 | 0.070 |
Why?
|
| Creatinine | 1 | 2012 | 1899 | 0.070 |
Why?
|
| Risk Factors | 9 | 2021 | 74167 | 0.070 |
Why?
|
| Balanitis | 1 | 2005 | 3 | 0.070 |
Why?
|
| Choristoma | 2 | 1998 | 206 | 0.070 |
Why?
|
| Remission, Spontaneous | 3 | 2009 | 384 | 0.060 |
Why?
|
| Laparoscopy | 3 | 2008 | 2035 | 0.060 |
Why?
|
| Endoscopy | 3 | 2017 | 1851 | 0.060 |
Why?
|
| Benchmarking | 1 | 2012 | 1045 | 0.060 |
Why?
|
| Testicular Diseases | 1 | 2005 | 73 | 0.060 |
Why?
|
| Scrotum | 3 | 2005 | 116 | 0.060 |
Why?
|
| Sensitivity and Specificity | 4 | 2018 | 14664 | 0.060 |
Why?
|
| Anxiety | 1 | 2020 | 4572 | 0.060 |
Why?
|
| Ultrasonography | 7 | 2022 | 5970 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2016 | 2523 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 17912 | 0.060 |
Why?
|
| Prostheses and Implants | 3 | 1991 | 1272 | 0.060 |
Why?
|
| Pyelonephritis | 4 | 1980 | 75 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2015 | 5246 | 0.060 |
Why?
|
| Prosthesis Failure | 2 | 2008 | 1204 | 0.060 |
Why?
|
| Sympathomimetics | 1 | 2003 | 56 | 0.060 |
Why?
|
| Heterozygote | 2 | 2020 | 2803 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2011 | 2223 | 0.050 |
Why?
|
| Microsurgery | 1 | 2008 | 795 | 0.050 |
Why?
|
| Evidence-Based Medicine | 2 | 2012 | 3687 | 0.050 |
Why?
|
| Observer Variation | 1 | 2009 | 2605 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 2022 | 10 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9606 | 0.050 |
Why?
|
| Radiography | 13 | 1997 | 6966 | 0.050 |
Why?
|
| Lipoma | 2 | 1997 | 293 | 0.050 |
Why?
|
| Teratoma | 1 | 2006 | 404 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2022 | 64 | 0.050 |
Why?
|
| Spinal Cord Neoplasms | 2 | 1997 | 263 | 0.050 |
Why?
|
| Spinal Cord Diseases | 2 | 1988 | 293 | 0.050 |
Why?
|
| Injections, Intramuscular | 1 | 2024 | 554 | 0.050 |
Why?
|
| Motor Neurons | 5 | 1995 | 870 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5794 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2008 | 2115 | 0.050 |
Why?
|
| Circumcision, Male | 2 | 2017 | 148 | 0.050 |
Why?
|
| Sex Factors | 4 | 2012 | 10548 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2011 | 1998 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18247 | 0.050 |
Why?
|
| Replantation | 3 | 1980 | 145 | 0.050 |
Why?
|
| Reference Standards | 2 | 2015 | 1004 | 0.050 |
Why?
|
| Radiopharmaceuticals | 3 | 2000 | 2651 | 0.050 |
Why?
|
| Rhabdomyosarcoma | 2 | 1996 | 358 | 0.050 |
Why?
|
| Lithotripsy | 1 | 2001 | 140 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 618 | 0.050 |
Why?
|
| Amphibian Proteins | 1 | 2020 | 36 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2020 | 12125 | 0.050 |
Why?
|
| Animals | 10 | 2021 | 168441 | 0.040 |
Why?
|
| Analysis of Variance | 4 | 2012 | 6231 | 0.040 |
Why?
|
| Incidence | 6 | 2018 | 21341 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 7409 | 0.040 |
Why?
|
| Home Nursing | 2 | 1998 | 92 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2016 | 3812 | 0.040 |
Why?
|
| Epispadias | 1 | 1999 | 19 | 0.040 |
Why?
|
| Digestive System | 1 | 2000 | 244 | 0.040 |
Why?
|
| Arabs | 1 | 2021 | 187 | 0.040 |
Why?
|
| Umbilical Arteries | 2 | 1978 | 79 | 0.040 |
Why?
|
| Reoperation | 6 | 2009 | 4303 | 0.040 |
Why?
|
| Larva | 1 | 2020 | 508 | 0.040 |
Why?
|
| Electric Stimulation Therapy | 2 | 2013 | 628 | 0.040 |
Why?
|
| Phenotype | 4 | 2020 | 16606 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2017 | 23441 | 0.040 |
Why?
|
| Disorders of Sex Development | 1 | 1999 | 129 | 0.040 |
Why?
|
| Xenopus | 1 | 2020 | 711 | 0.040 |
Why?
|
| Electrophysiology | 4 | 1997 | 1262 | 0.040 |
Why?
|
| Chondrocytes | 1 | 2003 | 795 | 0.040 |
Why?
|
| Genetic Counseling | 2 | 1979 | 627 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2018 | 1738 | 0.040 |
Why?
|
| Severity of Illness Index | 5 | 2015 | 15838 | 0.040 |
Why?
|
| Urogenital System | 1 | 2018 | 88 | 0.040 |
Why?
|
| Gestational Age | 1 | 2006 | 3576 | 0.040 |
Why?
|
| DNA | 2 | 2003 | 7219 | 0.040 |
Why?
|
| Vaginal Diseases | 1 | 1998 | 103 | 0.030 |
Why?
|
| Prospective Studies | 7 | 2020 | 54415 | 0.030 |
Why?
|
| Exons | 2 | 2018 | 2393 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2017 | 36423 | 0.030 |
Why?
|
| Umbilical Cord | 1 | 1978 | 179 | 0.030 |
Why?
|
| Nervous System | 1 | 2000 | 545 | 0.030 |
Why?
|
| Methods | 5 | 1990 | 1074 | 0.030 |
Why?
|
| Genome, Human | 1 | 2009 | 4425 | 0.030 |
Why?
|
| Kyphosis | 1 | 1998 | 237 | 0.030 |
Why?
|
| Chromosome Mapping | 3 | 2011 | 4638 | 0.030 |
Why?
|
| Reflex, Abnormal | 2 | 1994 | 83 | 0.030 |
Why?
|
| Ileum | 3 | 1989 | 557 | 0.030 |
Why?
|
| Vaginal Neoplasms | 1 | 1996 | 104 | 0.030 |
Why?
|
| Ureteral Diseases | 2 | 1989 | 63 | 0.030 |
Why?
|
| Consanguinity | 1 | 2018 | 456 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2003 | 1139 | 0.030 |
Why?
|
| Cystitis | 3 | 1994 | 95 | 0.030 |
Why?
|
| Lumbosacral Plexus | 1 | 1995 | 51 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2018 | 23990 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2015 | 174 | 0.030 |
Why?
|
| Mice | 6 | 2020 | 81509 | 0.030 |
Why?
|
| Perineum | 1 | 1996 | 208 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2015 | 293 | 0.030 |
Why?
|
| Urinary Fistula | 1 | 1994 | 42 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2018 | 1165 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2002 | 1755 | 0.030 |
Why?
|
| Cutaneous Fistula | 1 | 1994 | 79 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 1996 | 390 | 0.030 |
Why?
|
| Botulinum Toxins | 1 | 2015 | 189 | 0.030 |
Why?
|
| Nephrology | 1 | 2017 | 263 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2013 | 20556 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2863 | 0.030 |
Why?
|
| Hypertrophy | 2 | 2007 | 559 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 829 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2018 | 2748 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3702 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2281 | 0.030 |
Why?
|
| Athletes | 1 | 2021 | 1136 | 0.030 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2015 | 181 | 0.030 |
Why?
|
| Boston | 4 | 2017 | 9330 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 1069 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 1796 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 878 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14409 | 0.030 |
Why?
|
| China | 1 | 2019 | 2366 | 0.030 |
Why?
|
| Prevalence | 2 | 2021 | 15717 | 0.030 |
Why?
|
| Behavior Therapy | 2 | 2013 | 880 | 0.030 |
Why?
|
| Diagnosis, Differential | 5 | 2011 | 12970 | 0.030 |
Why?
|
| Nervous System Diseases | 2 | 1996 | 1666 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3418 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 2677 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2015 | 999 | 0.030 |
Why?
|
| Laxatives | 1 | 2013 | 92 | 0.030 |
Why?
|
| Prenatal Diagnosis | 2 | 2017 | 1265 | 0.020 |
Why?
|
| Rhombencephalon | 1 | 2012 | 81 | 0.020 |
Why?
|
| Cicatrix | 2 | 2012 | 798 | 0.020 |
Why?
|
| Models, Animal | 1 | 2018 | 2113 | 0.020 |
Why?
|
| Age Distribution | 1 | 1997 | 2880 | 0.020 |
Why?
|
| Ostomy | 1 | 2011 | 33 | 0.020 |
Why?
|
| Clinical Alarms | 1 | 2012 | 61 | 0.020 |
Why?
|
| Surgical Stomas | 1 | 2011 | 42 | 0.020 |
Why?
|
| Surgical Wound Dehiscence | 1 | 1992 | 213 | 0.020 |
Why?
|
| Logistic Models | 2 | 2015 | 13255 | 0.020 |
Why?
|
| Sleep Apnea, Central | 1 | 2012 | 88 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4510 | 0.020 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2012 | 188 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2013 | 461 | 0.020 |
Why?
|
| Genital Neoplasms, Male | 1 | 1990 | 68 | 0.020 |
Why?
|
| Alleles | 1 | 2021 | 6922 | 0.020 |
Why?
|
| Prolapse | 1 | 1990 | 63 | 0.020 |
Why?
|
| Electrolytes | 1 | 2011 | 274 | 0.020 |
Why?
|
| Constriction, Pathologic | 2 | 2011 | 1097 | 0.020 |
Why?
|
| Catheterization | 1 | 1975 | 1432 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1975 | 591 | 0.020 |
Why?
|
| Recurrence | 4 | 2011 | 8469 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 12688 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 3 | 1989 | 1626 | 0.020 |
Why?
|
| Mesencephalon | 1 | 2012 | 332 | 0.020 |
Why?
|
| Organ Size | 1 | 2015 | 2254 | 0.020 |
Why?
|
| Base Sequence | 2 | 2015 | 12450 | 0.020 |
Why?
|
| Family | 1 | 2020 | 3197 | 0.020 |
Why?
|
| Contrast Media | 1 | 2022 | 5311 | 0.020 |
Why?
|
| Cohort Studies | 4 | 2015 | 41446 | 0.020 |
Why?
|
| Dilatation, Pathologic | 4 | 1989 | 527 | 0.020 |
Why?
|
| Risk | 4 | 1984 | 9612 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2011 | 587 | 0.020 |
Why?
|
| Lod Score | 1 | 2009 | 602 | 0.020 |
Why?
|
| Protein Binding | 1 | 2020 | 9352 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2012 | 773 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2645 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 17644 | 0.020 |
Why?
|
| Netherlands | 1 | 2013 | 2221 | 0.020 |
Why?
|
| Reflex | 1 | 1989 | 376 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2018 | 5439 | 0.020 |
Why?
|
| Siblings | 1 | 2011 | 825 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2004 | 7856 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2977 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 2011 | 496 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 2020 | 0.020 |
Why?
|
| Ischemia | 1 | 1995 | 1877 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2020 | 22168 | 0.020 |
Why?
|
| Radionuclide Imaging | 3 | 2000 | 1975 | 0.020 |
Why?
|
| Pregnancy | 3 | 2003 | 29862 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2012 | 748 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2000 | 12330 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 13449 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4278 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 1994 | 1671 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 1188 | 0.020 |
Why?
|
| Psychometrics | 1 | 2015 | 3065 | 0.020 |
Why?
|
| Scoliosis | 1 | 2012 | 740 | 0.020 |
Why?
|
| Walking | 1 | 1992 | 1200 | 0.020 |
Why?
|
| Postoperative Period | 2 | 2006 | 1815 | 0.020 |
Why?
|
| Thymine | 1 | 2004 | 68 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 4741 | 0.010 |
Why?
|
| Infertility, Male | 1 | 2007 | 396 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 2006 | 449 | 0.010 |
Why?
|
| Congenital Abnormalities | 2 | 1998 | 709 | 0.010 |
Why?
|
| Jejunum | 1 | 1985 | 472 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 2006 | 568 | 0.010 |
Why?
|
| Sertoli Cell Tumor | 1 | 1983 | 36 | 0.010 |
Why?
|
| Cytosine | 1 | 2004 | 211 | 0.010 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1983 | 67 | 0.010 |
Why?
|
| Guanine | 1 | 2004 | 279 | 0.010 |
Why?
|
| Pentetic Acid | 1 | 1983 | 209 | 0.010 |
Why?
|
| Technetium | 1 | 1983 | 322 | 0.010 |
Why?
|
| Proline | 1 | 2004 | 457 | 0.010 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 1983 | 104 | 0.010 |
Why?
|
| Urothelium | 1 | 2004 | 269 | 0.010 |
Why?
|
| Genitalia, Female | 1 | 1983 | 147 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2003 | 255 | 0.010 |
Why?
|
| Algorithms | 2 | 2015 | 14026 | 0.010 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2002 | 168 | 0.010 |
Why?
|
| Retreatment | 1 | 2003 | 598 | 0.010 |
Why?
|
| Postoperative Care | 2 | 1999 | 1471 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2851 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11073 | 0.010 |
Why?
|
| Alanine | 1 | 2004 | 608 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 981 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 11902 | 0.010 |
Why?
|
| Linear Models | 2 | 2005 | 5869 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1986 | 1201 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2003 | 591 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 2003 | 591 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 701 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 687 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5670 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2002 | 1152 | 0.010 |
Why?
|
| Preoperative Care | 2 | 1999 | 2242 | 0.010 |
Why?
|
| Diagnostic Errors | 2 | 1998 | 1265 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2012 | 2785 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1999 | 285 | 0.010 |
Why?
|
| Wilms Tumor | 1 | 1981 | 379 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 5492 | 0.010 |
Why?
|
| Gastrointestinal Motility | 1 | 2000 | 234 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 1675 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1246 | 0.010 |
Why?
|
| Meckel Diverticulum | 1 | 1978 | 32 | 0.010 |
Why?
|
| Radioisotope Renography | 1 | 1998 | 61 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2003 | 1674 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1999 | 1157 | 0.010 |
Why?
|
| Groin | 1 | 1998 | 106 | 0.010 |
Why?
|
| Ligaments | 1 | 1998 | 127 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 2642 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3597 | 0.010 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1998 | 133 | 0.010 |
Why?
|
| Testicular Neoplasms | 1 | 1983 | 799 | 0.010 |
Why?
|
| Hernia, Umbilical | 1 | 1978 | 102 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1998 | 2089 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1987 | 3057 | 0.010 |
Why?
|
| Bacteriuria | 2 | 1989 | 102 | 0.010 |
Why?
|
| Epilepsy | 1 | 2012 | 3290 | 0.010 |
Why?
|
| Surgery, Plastic | 1 | 1983 | 643 | 0.010 |
Why?
|
| Estradiol | 1 | 1983 | 1937 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1651 | 0.010 |
Why?
|
| Motor Neuron Disease | 1 | 1996 | 97 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 10203 | 0.010 |
Why?
|
| United States | 1 | 2024 | 72339 | 0.010 |
Why?
|
| Hypertension | 1 | 1975 | 8542 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 6215 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 6086 | 0.010 |
Why?
|
| Urinary Retention | 1 | 1995 | 106 | 0.010 |
Why?
|
| Diet | 1 | 2013 | 8074 | 0.010 |
Why?
|
| Appendix | 1 | 1995 | 109 | 0.010 |
Why?
|
| Renal Artery Obstruction | 1 | 1975 | 219 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2003 | 2455 | 0.010 |
Why?
|
| Vas Deferens | 1 | 1994 | 54 | 0.010 |
Why?
|
| Abscess | 1 | 1978 | 606 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2003 | 4124 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2012 | 12951 | 0.010 |
Why?
|
| Biopsy | 1 | 2006 | 6766 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1996 | 11118 | 0.010 |
Why?
|
| Penis | 1 | 1994 | 212 | 0.010 |
Why?
|
| Nonlinear Dynamics | 1 | 1996 | 492 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 1980 | 1301 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1998 | 1068 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3712 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2005 | 3600 | 0.010 |
Why?
|
| Testosterone | 1 | 1983 | 2472 | 0.010 |
Why?
|
| Counseling | 1 | 1980 | 1546 | 0.010 |
Why?
|
| Colon | 1 | 2000 | 1792 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 8320 | 0.010 |
Why?
|
| Cell Division | 1 | 1999 | 4466 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 7584 | 0.010 |
Why?
|
| Hernia, Inguinal | 1 | 1994 | 220 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1990 | 374 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1990 | 304 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 1996 | 809 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 4921 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 4725 | 0.010 |
Why?
|
| Radiotherapy, High-Energy | 1 | 1990 | 228 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 13009 | 0.010 |
Why?
|
| Body Height | 1 | 1996 | 1570 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1994 | 1083 | 0.000 |
Why?
|
| Orchiectomy | 1 | 1990 | 463 | 0.000 |
Why?
|
| Vincristine | 1 | 1990 | 1036 | 0.000 |
Why?
|
| Cecum | 1 | 1989 | 233 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 2003 | 18964 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 2 | 1994 | 1923 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 2002 | 14599 | 0.000 |
Why?
|
| Neural Inhibition | 1 | 1989 | 590 | 0.000 |
Why?
|
| Artifacts | 1 | 1994 | 1910 | 0.000 |
Why?
|
| Sex Characteristics | 1 | 1996 | 2637 | 0.000 |
Why?
|
| Body Weight | 1 | 1996 | 4618 | 0.000 |
Why?
|
| Cyclophosphamide | 1 | 1990 | 2218 | 0.000 |
Why?
|
| Lymph Node Excision | 1 | 1990 | 1271 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1999 | 12796 | 0.000 |
Why?
|
| Doxorubicin | 1 | 1990 | 2224 | 0.000 |
Why?
|
| Graft Survival | 1 | 1994 | 3819 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1996 | 10089 | 0.000 |
Why?
|
| Gram-Positive Bacteria | 1 | 1984 | 177 | 0.000 |
Why?
|
| Sertoli Cells | 1 | 1983 | 50 | 0.000 |
Why?
|
| Desmosomes | 1 | 1983 | 72 | 0.000 |
Why?
|
| Oligospermia | 1 | 1983 | 59 | 0.000 |
Why?
|
| Vulva | 1 | 1983 | 84 | 0.000 |
Why?
|
| Diuresis | 1 | 1983 | 106 | 0.000 |
Why?
|
| Muscles | 1 | 1987 | 1576 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1990 | 4852 | 0.000 |
Why?
|
| Basement Membrane | 1 | 1983 | 349 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1983 | 698 | 0.000 |
Why?
|
| Epididymitis | 1 | 1981 | 37 | 0.000 |
Why?
|
| Thrombosis | 1 | 1975 | 2942 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1983 | 2561 | 0.000 |
Why?
|
| Syndrome | 1 | 1984 | 3268 | 0.000 |
Why?
|
| Vagina | 1 | 1983 | 838 | 0.000 |
Why?
|
| Myelitis, Transverse | 1 | 1977 | 40 | 0.000 |
Why?
|
| Renal Artery | 1 | 1978 | 351 | 0.000 |
Why?
|
| Tuberous Sclerosis | 1 | 1983 | 1030 | 0.000 |
Why?
|
| Angiography | 1 | 1978 | 1599 | 0.000 |
Why?
|
| Drainage | 1 | 1978 | 1156 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1984 | 4218 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1990 | 11740 | 0.000 |
Why?
|
| Middle Aged | 2 | 1995 | 220826 | 0.000 |
Why?
|
| Decision Making | 1 | 1981 | 3929 | 0.000 |
Why?
|